Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Mol Immunol. 2008 Mar 4;45(9):2429–2436. doi: 10.1016/j.molimm.2008.01.002

Table 1.

Summary of Associations of SC and CV with HLA-class I, II and KIR.

Injection Drug Users (IDU) Blood Transfusion IDU and Blood Transfusion Unknown
HLA association SC CV SC CV SC CV SC CV
Reference
(Ethnicity)
Reference
(Ethnicity)
Reference
(Ethnicity)
Reference
(Ethnicity)
Reference
(Ethnicity)
Reference
(Ethnicity)
Reference
(Ethnicity)
Reference
(Ethnicity)
HLA-DRB1*0101 (Mangia, 1999; McKierman 2004, Fanning, 2000; McKierman 2000;Barret,1999) (C) (Thio, 2001) (AA and C)
HLA-DRB1*0104 (Cramp, 1998) (C)
HLA-DRB1*0301 (McKierman 2004) (C) (Thio, 2001) (C) (Yenigun, 2002) (C)
HLA-DRB1*0401 (McKierman 2000) (C) (Cramp, 1998)(C)
HLA-DRB1*0701 (Thursz, 1999) (C)
HLA-DRB1*1101 Present report (H) (trend) (Thursz, 1999) (C) (Holer, 1997) (T)
HLA-DRB1*1201 Present report (H)
HLA-DRB1*1301 (Holer, 1997) (C)
HLA-DRB1*1501 (Lechmann 1999) (C) (Lechmann, 1999) (C)
HLA-DQA1*0103 (Holer, 1997) (C)
HLA-DQA1*0201 (Zavaglia, 1998) (C)
HLA-DQA1*0301 (Cramp, 1998) (C)
HLA-DQA1*0801 (Zavaglia 1998) (C)
HLA-DQB1*0201 (McKierman 2004) (C) (Zavaglia, 1998) (C)
HLA-DQB1*0301 (Thio, 2001), (Cramp,1998) (AA and C)
HLA-DQB1*0501 (Azocar, 2003) (trend)(H) Present report (H) (McKierman 2004) (C) (Thio, 2001) (AA and C)
HLADRB1*1101/DQB1*0301 (Yee, 2004) (C) (Thursz, 1999; Alric, 1997; Minton 1998) (C)
HLA-DRB1*1104/DQB1*0301 (Mangia 1999)(C) (Zavaglia, 1998) (C)
HLA-DRB1*12
HLA C1/C1/KIR 2DL3/2DL3 (Khakoo, 2004)(AA); (Khakoo, 2004) (C)
HLA C1/C1/KIR2DL3/2DL3 + HLADRB1*1201

SC: Spontaneous Clearance; CV: Chronic Viremia; C: Caucasian; AA: African American; Hispanic;

HHS Vulnerability Disclosure